Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers

NCT05159427 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Human Gastrointestinal Physiology Data

Interventions

DRUG: Glucotrol XL 5Mg Extended-Release Tablet
DRUG: Glipizide ER 5 MG 24 HR Extended Release Oral Tablet
DRUG: Rifaximin 200Mg Tab
DRUG: 13C6-Glipizide

Sponsor

University of Michigan

Collaborators

[object Object]